TP53 and hepatocellular carcinoma: Proliferative HCC is associated with TP53 mutations, chromosomal instability, and aggressive tumor behaviors, leading to a higher recurrence rate and worse overall survival after intended curative surgery or transarterial chemoembolization (TACE) [5–7].